It can be said that this child is very, very lucky. It is understood that this child has been taking clobactam for nearly five years. Because there was no such life-saving medicine in China before, her mother bought it from abroad, but she often faced the risk of stopping using it when buying it abroad. If she takes it irregularly for a long time, the disease will recur and even lead to serious complications, which is very unfavorable to the safety of children. Now, this medicine has been launched in China, so that children will never face the risk of stopping taking it, and they don't have to worry about buying fake drugs.
You should know that the drugs distributed by hospitals are all distributed through formal channels. Chlorbazine can treat a rare disease: epileptic encephalopathy, intractable epilepsy in children and epilepsy that cannot be treated by other antiepileptic drugs. Because of its complicated etiology and few drugs, it is a disease that is difficult to cure. Because its incidence is very low, about1100000 to 2/ 100000. Few countries can produce clobactam, a therapeutic drug. Many patients' families go abroad to buy.
Since clobactam is the second psychotropic drug, this will be a big problem. The National Health Commission and the US Food and Drug Administration jointly formulated and issued a work plan for the temporary import of chloropropionic acid. According to the plan, Peking Union Medical College Hospital will take the lead in promoting the use of chlorhexidine in 50 tertiary hospitals, and children and their families can purchase chlorhexidine through prescriptions of qualified doctors. Citizens of China are not allowed to buy or exchange this special medicine, nor is it allowed by law. But this is a specific medicine, which can treat rare epilepsy.
Without this medicine, it is difficult to control children's symptoms. Therefore, this is a very contradictory conflict: if you can't successfully enter the market, then children's diseases can't be controlled, but it's not easy to successfully enter the market. In order to get better treatment for children, the relevant departments have also made great efforts to make this drug legally listed.